Report of the Eleventh Meeting of the CGIAR Private Sector Committee

cg.subject.systemCGIAR meeting 1999/10en
cg.subject.systemBiotechnologyen
cg.subject.systemCGIAR committeesen
cg.subject.systemCGIAR Private Sector Committeeen
cg.subject.systemCGIAR private sector relationsen
cg.subject.systemCGIAR System Reviewen
cg.subject.systemHigh level private sector conferenceen
cg.subject.systemIARC private sector relationsen
cg.subject.systemIntellectual property rightsen
cg.subject.systemIRRIen
cg.subject.systemPlant breedingen
cg.subject.systemPrivate sector perspectiveen
cg.subject.systemProprietary science and technologyen
cg.subject.systemRiceen
cg.subject.systemUSAIDen
dc.contributor.authorCGIAR Private Sector Committeeen
dc.date.accessioned1999-10-01T00:00:01Zen
dc.date.available1999-10-01T00:00:01Zen
dc.identifier.urihttps://hdl.handle.net/10947/1048
dc.titleReport of the Eleventh Meeting of the CGIAR Private Sector Committeeen
dcterms.abstractReport of the eleventh meeting of the CGIAR Private Sector Committee held at the World Bank in Washington, D.C. on conjunction with ICW 99, chaired by Sam Dryden. Per Pinstrup-Andersen, Director General of IFPRI and incoming chair of the CDC, participated. The Committee discussed its role as revised by the system review process. Members agreed that it should provide policy advice to the CGIAR based on members' experience of private sector views and practices. The theme for the meeting was The Impending Impasse in Advanced Breeding and the Use of Proprietary Technology. Discussion utilized an ISNAR survey of proprietary science. The concern was that centers could face litigation if the properly licensed use of proprietary technologies was in question. There might also be a contributory infringement problem for donors. The public debate on biotechnology, and the danger that center application of advanced methods would be impeded was also discussed. A number of ways to overcome the impasse were explored, but each had some flaws.The Committee urged a complete inventory of center use of proprietary technology, and determination of ownership and the actions needed to permit dissemination of products. The planned high level dialogue between the CGIAR Chairman and major CEOs might help. The CGIAR could assist the private sector by providing public endorsements for biotechnology products. The Committee accepted a USAID invitation to cosponsor a workshop with IRRI and others on the impact of IPR on rice research.Agenda document, CGIAR International Centers Week, October, 1999.en
dcterms.accessRightsOpen Access
dcterms.issued1999-10-01
dcterms.languageen
dcterms.typeMeeting Report

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
psc011.pdf
Size:
314.4 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: